LOINC Code 105941-9: Multiple myeloma minimal residual disease analysis NAA+non-probe Ql (BM)

What is this code?

LOINC codes identify tests, measurements, observations, survey items, and clinical questions in a standardized way. It is associated with the component Multiple myeloma minimal residual disease analysis. It is commonly used with the system or sample type Bone mar.

When is it used?

• Used in lab systems, EHRs, and clinical data exchange.
• May identify a test, observation, survey item, or clinical document request rather than a diagnosis.
• Status: ACTIVE
• Order vs observation: Both
• Method: Non-probe.amp.tar

What it does not mean

• The code identifies the observation or test, not the actual result.

Key facts

• Multiple myeloma minimal residual disease analysis [Presence] in Bone marrow by NAA with non-probe detection
• Multiple myeloma minimal residual disease analysis
• This test is to detect the minimal residual disease (MRD) or the small number of Multiple myeloma cancer cells that may remain in a patient's body after treatment and are not detectable using conventional diagnostic methods.
• 3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; BM; BON; Bone marrow; Dis; Diseases; DNA NUCLEIC ACID PROBE; DNA probe; Dz; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; MAR; Marrow (bone); minimal angle of resolution; Minimum angle of resolution; MM MRD anlyss; Molecular pathology; MOLPATH; Mult; Multi; NAA+n-prb; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Screen; SDA; Strand Displacement Amplification; TMA; Transcription mediated amplification

Where you may see this code

You may see this code in lab systems, lab reports, EHR exports, interoperability feeds, or other structured clinical data exchanges.

Common synonyms

Frequently asked questions